NUCLEOLIN and cancer: The anti-nucleolin VHH-Fc antibody presented increased effects relative to other agents targeting nucleolin, including the AS1411 aptamer and the HB-19 and N6L pseudopeptides, which impacted cancer cell viability in the micromolar range6,10,11.